Job Opening: Applications Scientist
This position with Early Charm Ventures' portfolio company, SilcsBio, centers on deploying SilcsBio's software platform to perform molecular modeling and interface with customers for technical support and sales.
Early Charm Announces Hiring of Kurt McWilliams as Director of R&D for Materic
McWilliams, a patent attorney, also to take on role of Intellectual Property Counsel for Early Charm July 20, 2022, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Kurt McWilliams – a seasoned Intellectual Property (IP) attorney, polymer scientist and organic chemist – as
Synteris Awarded $2.7 Million for 3D Printing Ceramics for Power Electronics
Funding is Part of DoE’s Advanced Research Projects Agency-Energy (ARPA-E) OPEN 2021 Program to Strengthen US Advanced Energy Goals June 21, 2022, Baltimore, MD – Synteris, a company commercializing technology for net-shape 3D printing of non-oxide ceramic parts, today announced it has been awarded a $2.7 million grant from the US Department of Energy’s
Early Charm Announces Hiring of Abhishek Kognole as Applications Scientist
Kognole background as a computational chemist and a biophysicist to fuel product development and client services for Rasio Therapeutics and SilcsBio May 5, 2022, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Abhishek Kognole, PhD, a computational chemist and a
Minnowtech Announces Hiring of Daniel Nafarrete as Aquaculture R&D Technician
Nafarrete brings his technology skills and experience to applying Minnowtech’s sonar-based system at a shrimp farm in Kauai March 15, 2022, Kekaha, HI – Minnowtech, an aquaculture technology company that enables shrimp farmers to calculate shrimp abundance for optimizing feed and harvest, today announced the hiring of Daniel Nafarrete as Aquaculture R&D Technician, located at
Materic and Coppin Partner to Develop New Smart Garment Tech
Materic’s team to partner with Coppin’s Center for Nanotechnology to drive new smart fibers to market February 21, 2022, Baltimore, MD – Coppin State University and Materic, LLC have announced the launch of a joint development effort to develop pressure responsive fibers for use in smart garments. Materic and Coppin intend to develop commercially relevant
Electrospinning Web Series Continues with Jan. 20 Event on Electrospinning in Electronics & Sensors
Materic’s virtual, free Webinar Events aim to build community of professionals in the electrospinning field and spur collaboration January 7, 2022, Baltimore, MD – Materic, a custom designer and manufacturer of advanced materials, begins the third-quarter of its successful Electrospinning Web Series with a focus on “Electrospinning in Electronics and Sensors.” Materic’s Q3 kicks off
Rasio Therapeutics Raises $1.5 Million to Advance Drug Development
New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research December 2, 2021, Baltimore, MD – Rasio Therapeutics a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop new drugs for oncology, today announced it has received $1.5 million in new financing.
Early Charm Announces Hiring of Mary Beth Wickless as Blue Economy Portfolio Analyst
Wickless’s business and market analysis skills and experience to help accelerate growth of Early Charm’s Blue Economy portfolio of companies December 1, 2021, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Mary Beth Wickless, a seasoned business and market analyst,
ComputChem Awarded $1,373,997in SBIR Phase II Funding from the National Institutes of Health
SBIR award will enable ComputChem to create software for better drug design and development November 19, 2021, Baltimore, MD – ComputChem, a technology company building next-generation platform solutions for in silico covalent drug design and lead optimization, today announced it has been awarded a $1,373,997 Small Business Innovation Research (SBIR) Phase II grant from the
